This Article Full Text Full Text (PDF) All Versions of this Article: 35/11/2429    most recent 01.STR.0000146712.80466.bev1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hachinski, V. Search for Related Content PubMed Articles by Hachinski, V. Related Collections Acute coronary syndromes

(Stroke. 2004;35:2429.)
© 2004 American Heart Association, Inc.

Editorial

Stroke Supplements

The Princeton Conference

From the London Health Sciences Center, University of Western Ontario, London, Ontario, Canada.

Correspondence to Dr Vladimir Hachinski, Department of Clinical Neurological Sciences, London Health Sciences Center, 339 Windermere Rd, London, ON, Canada N6A 5A5.

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Journal supplements have a mixed reputation. Too often they represent the non-peer–reviewed proceedings from a conference sponsored by an organization with a viewpoint to push, or a pharmaceutical company with a product to sell. Supplements reached such low ebb that they were discontinued by the Scientific Publications Committee of the American Heart Association (AHA). Recently the AHA has encouraged the publication of journal supplements, if they can meet a new high standard. The articles must be peer-reviewed, and follow a scientific or educational logic for why the articles should be presented in a single publication. The supplement must be sponsored by a medical society, a government agency, or be continuous medical education (CME) accredited. A minimum of two industry sponsors is preferable. Supplements should not focus on a single product, nor be perceived as endorsing a particular one.

We had been looking for an opportunity to begin a new series of supplements, with an exemplary first issue. The opportunity came in the form of the 24^th Princeton Conference of Cerebral Vascular Diseases. It covers clinical and basic sciences, and aims to give equal time to presentations and discussion. This is the premier research meeting in our field. The first took place at Princeton, New Jersey in 1954, and since 1966 it has been held every other year in the city of the organizer of turn.

The 24^th Princeton Conference featured a systematic effort at integrating the clinical and basic sciences. Papers on a given topic were presented in the same . . . [Full Text of this Article]